Key Events This Week
25 May: Stock opens at ₹28.00, down 3.88% from previous week
27 May: Valuation shifts to Very Attractive despite weak returns
29 May: Rating upgraded to Sell from Strong Sell amid mixed signals
29 May: Week closes at ₹28.00, down 0.21% on the day

Link Pharma Chem Ltd Upgraded to Sell Amid Mixed Financial and Valuation Signals
2026-05-28 08:17:15Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating downgraded from Strong Sell to Sell as of 27 May 2026. This adjustment reflects a complex interplay of deteriorating financial trends, improved valuation metrics, and mixed technical signals, underscoring the challenges and opportunities facing the company in a volatile market environment.
Read full news article
Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amidst Challenging Returns
2026-05-27 08:00:30Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite this positive change in valuation metrics, the company continues to grapple with weak profitability and underwhelming returns, raising questions about the sustainability of its current market price.
Read full news articleLink Pharma Chem Ltd Gains 0.83%: Margin Pressures and Operational Losses Define Week
2026-05-23 17:17:45
Key Events This Week
18 May: Stock opens steady at Rs.28.89 amid weak Sensex close
19 May: Sharp decline of 4.29% to Rs.27.65 on volume spike
20 May: Strong recovery with 4.99% gain to Rs.29.03
21 May: Continued rally, closing at Rs.29.88 (+2.93%)
22 May: Quarterly results reveal flat performance; stock closes at Rs.29.13 (-2.51%)
Are Link Pharma Chem Ltd latest results good or bad?
2026-05-22 19:24:20Link Pharma Chem Ltd's latest financial results for Q4 FY26 reveal a challenging operational landscape. The company reported a net loss of ₹0.41 crores, which represents a deepening of losses compared to the previous year’s loss of ₹0.35 crores. This marks the second consecutive quarterly loss, indicating ongoing difficulties in achieving profitability. Revenue for the quarter was ₹6.59 crores, showing a modest year-on-year increase of 2.17% from ₹6.45 crores in Q4 FY25, but reflecting a sequential decline of 2.08% from ₹6.73 crores in Q3 FY26. This suggests that while there was some year-over-year growth, the company struggled to maintain momentum from the prior quarter. The operating margin for the quarter was recorded at -3.49%, the lowest in the company's history, which is a significant decline from the -3.41% margin in the same quarter last year. This volatility in margins highlights operational inst...
Read full news article
Link Pharma Chem Q4 FY26: Losses Deepen Amid Persistent Operational Challenges
2026-05-22 11:46:37Link Pharma Chem Ltd., a micro-cap commodity chemicals manufacturer, reported a net loss of ₹0.41 crores for Q4 FY26 (quarter ending March 2026), marking the second consecutive quarter of losses and reflecting continued operational difficulties at the Vadodara-based thionyl chloride producer. The ₹13.00-crore market capitalisation company saw its stock decline 4.95% to ₹28.40 following the results announcement, extending its underperformance against both the benchmark index and the broader commodity chemicals sector.
Read full news article
Link Pharma Chem Ltd Reports Flat Quarterly Performance Amid Margin Pressures
2026-05-22 11:00:09Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. The company’s latest quarterly results reveal significant margin contraction and operating losses, raising concerns about its near-term profitability and overall financial health.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
23-May-2026 | Source : BSENewspaper Publication of Audited Financial Result of the Company for the Quarter and year ended 31st March 2026. Published on 23rd May 2026 in Business Standard (English Edition) and Loksatta (Gujarati Edition).
Non Applicability Of Regulations 23(9) Of SEBI (LODR) Regulations 2015 On Disclosure Of Related Party Transactions For The Half Year Ended On 31St March 2026.
21-May-2026 | Source : BSENon Applicability of Regulations 23(9) of SEBI (LODR) Regulations 2015 on Disclosure of Non Applicability of reporting of Related Party Transactions for the Half year ended on 31st March 2026.
Announcement under Regulation 30 (LODR)-Change in Management
21-May-2026 | Source : BSERe-appointment of Mr. Rishikesh S. Thakur as Managing Director of the Company for 3 years.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







